Skip to main content
logo
TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.260
+0.050 (4.13%)
At close: May 8, 2026, 4:00 PM EDT
1.300
+0.040 (3.17%)
After-hours: May 8, 2026, 7:45 PM EDT

TScan Therapeutics Revenue

TScan Therapeutics had revenue of $982.00K in the quarter ending March 31, 2026, a decrease of -54.77%. This brings the company's revenue in the last twelve months to $9.14M, up 106.65% year-over-year. In the year 2025, TScan Therapeutics had annual revenue of $10.33M with 266.65% growth.

Revenue (ttm)
$9.14M
Revenue Growth
+106.65%
P/S Ratio
8.29
Revenue / Employee
$64,338
Employees
142
Market Cap
75.73M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202510.33M7.51M266.65%
Dec 31, 20242.82M-18.23M-86.62%
Dec 31, 202321.05M7.51M55.52%
Dec 31, 202213.54M3.39M33.47%
Dec 31, 202110.14M9.06M834.65%
Dec 31, 20201.09M--
Dec 31, 2019---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

TCRX News

More News